T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Bankunited
BKU
$3.37B
| $206M | 0.04% |
6,692,431
+772,756
| +13% | +$25.7M |
|
402
Aon
AON
$74.7B
| $205M | 0.04% |
1,873,693
+165,136
| +10% | +$17.5M |
|
|
KKD
403
DELISTED
KRISPY KREME DOUGHNUTS INC
KKD
| $205M | 0.04% |
9,759,285
-977,939
| -9% | -$18.8M |
|
404
Vipshop
VIPS
$6.94B
| $204M | 0.04% |
18,251,550
-283,818
| -2% | -$3.47M |
|
|
ZEN
405
DELISTED
ZENDESK INC
ZEN
| $203M | 0.04% |
7,694,293
+2,651,239
| +53% | +$64M |
|
|
TFCFA
406
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $202M | 0.04% |
7,477,354
-8,953,858
| -54% | -$261M |
|
|
WRI
407
DELISTED
Weingarten Realty Investors
WRI
| $202M | 0.04% |
4,936,391
+374,193
| +8% | +$14.2M |
|
408
Lumen
LUMN
$6.53B
| $199M | 0.04% |
6,856,175
-85,720
| -1% | -$2.5M |
|
|
MON
409
DELISTED
Monsanto Co
MON
| $198M | 0.04% |
1,916,965
+110,339
| +6% | +$10.9M |
|
|
WRK
410
DELISTED
WestRock Company
WRK
| $198M | 0.04% |
5,093,697
-1,181,887
| -19% | -$44.3M |
|
|
WMGI
411
DELISTED
Wright Medical Group Inc
WMGI
| $198M | 0.04% |
11,381,689
+1,649,553
| +17% | +$30.3M |
|
|
MKTO
412
DELISTED
MARKETO INC COM STK (DE)
MKTO
| $197M | 0.04% |
5,649,117
-1,771,905
| -24% | -$49M |
|
413
TJX Companies
TJX
$170B
| $196M | 0.04% |
5,088,340
-180,496
| -3% | -$6.89M |
|
414
Texas Capital Bancshares
TCBI
$4.36B
| $196M | 0.04% |
4,197,058
+158,660
| +4% | +$7.11M |
|
|
DPLO
415
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $195M | 0.04% |
5,574,083
-48,851
| -0.9% | -$1.54M |
|
|
GAP
416
The Gap Inc
GAP
$7.32B
| $193M | 0.04% |
9,079,555
+3,623,790
| +66% | +$77.2M |
|
|
AVNS
417
DELISTED
Avanos Medical
AVNS
| $192M | 0.04% |
5,915,008
+213,040
| +4% | +$6.53M |
|
|
CYBR
418
DELISTED
CyberArk
CYBR
| $192M | 0.04% |
3,948,816
+1,466,040
| +59% | +$63.3M |
|
|
GRUB
419
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $191M | 0.04% |
3,073,233
-250,143
| -8% | -$13.1M |
|
|
EVHC
420
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $190M | 0.04% |
2,498,788
-175,440
| -7% | -$12.5M |
|
|
DCT
421
DELISTED
DCT Industrial Trust Inc.
DCT
| $190M | 0.04% |
3,949,170
-91,835
| -2% | -$3.91M |
|
422
Macy's
M
$6.25B
| $189M | 0.04% |
5,624,616
-31,648
| -0.6% | -$1.13M |
|
423
TripAdvisor
TRIP
$1.23B
| $189M | 0.04% |
2,939,211
+17,590
| +0.6% | +$1.14M |
|
424
Rollins
ROL
$17.6B
| $188M | 0.04% |
14,456,957
+4,246,268
| +42% | +$52.1M |
|
425
PPG Industries
PPG
$25.6B
| $188M | 0.04% |
1,804,287
-54,803
| -3% | -$5.98M |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.